BIOMAT Database Logo BIOMAT Database Logo

Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? 1999

C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Institut de Génétique Moléculaire, UMR5535 - CNRS, Montpellier, France.

The c-Fos and c-Jun oncoproteins and the p53 tumor suppressor protein are short-lived transcription factors. Several catabolic pathways contribute to their degradation in vivo. c-Fos and c-Jun are thus mostly degraded by the proteasome, but there is indirect evidence that, under certain experimental/physiological conditions, calpains participate in their destruction, at least to a limited extent. Lysosomes have also been reported to participate in the destruction of c-Fos. Along the same lines, p53 is mostly degraded following the ubiquitin/proteasome pathway and calpains also seem to participate in its degradation. Moreover, c-Fos, c-Jun and p53 turnovers are regulated upon activation of intracellular signalling cascades. All taken together, these observations underline the complexity of the mechanisms responsible for the selective destruction of proteins within cells.

UI MeSH Term Description Entries
D009097 Multienzyme Complexes Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES. Complexes, Multienzyme
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D016755 Proto-Oncogene Proteins c-jun Cellular DNA-binding proteins encoded by the c-jun genes (GENES, JUN). They are involved in growth-related transcriptional control. There appear to be three distinct functions: dimerization (with c-fos), DNA-binding, and transcriptional activation. Oncogenic transformation can take place by constitutive expression of c-jun. c-fos-Associated Protein p39,c-jun Proteins,fos-Associated Protein p39,jun B Proteins,jun D Proteins,jun Proto-Oncogene Proteins,p39(c-jun),Proto-Oncogene Products c-jun,Proto-Oncogene Proteins jun,jun Proto-Oncogene Product p39,p39 c-jun,Proto Oncogene Products c jun,Proto Oncogene Proteins c jun,Proto Oncogene Proteins jun,c fos Associated Protein p39,c jun Proteins,fos Associated Protein p39,jun Proto Oncogene Product p39,jun Proto Oncogene Proteins,p39 c jun
D016760 Proto-Oncogene Proteins c-fos Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes. Fos B Protein,Fos-Related Antigen,Fos-Related Antigens,c-fos Protein,c-fos Proteins,fos Proto-Oncogene Protein,fos Proto-Oncogene Proteins,p55(c-fos),Antigens, Fos-Related,FRAs,Proto-Oncogene Products c-fos,Proto-Oncogene Proteins fos,p55 c-fos,Antigen, Fos-Related,Fos Related Antigen,Fos Related Antigens,Protein, c-fos,Protein, fos Proto-Oncogene,Proto Oncogene Products c fos,Proto Oncogene Proteins c fos,Proto Oncogene Proteins fos,Proto-Oncogene Protein, fos,c fos Protein,c fos Proteins,fos Proto Oncogene Protein,fos Proto Oncogene Proteins,p55 c fos

Related Publications

C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Degradation of c-Fos by the 26S proteasome is accelerated by c-Jun and multiple protein kinases.
October 1995, Molecular and cellular biology,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Complex mechanisms for c-fos and c-jun degradation.
March 1997, Molecular biology reports,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
In vivo effects of adrenocorticotropin on c-jun, jun-B, c-fos and fos-B in rat adrenal.
January 1995, Endocrine research,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Degradation of transcription factors, c-Jun and c-Fos, by calpain.
August 1991, FEBS letters,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Multiple signal transduction pathways mediate c-Jun protein phosphorylation.
May 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
c-jun and c-fos are expressed by human megakaryocytes.
August 1992, Experimental hematology,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Multiple degradation pathways for Fos family proteins.
November 2002, Annals of the New York Academy of Sciences,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars.
December 1999, Journal of dermatological science,
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun.
December 1992, Science (New York, N.Y.),
C Salvat, and C Aquaviva, and I Jariel-Encontre, and P Ferrara, and M Pariat, and A M Steff, and S Carillo, and M Piechaczyk
c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors.
December 2005, Bone,
Copied contents to your clipboard!